Laboratorios Andromaco S.A. clinical trials

Acquired by Grünenthal GmbH, Dec 2013 · source ↗

The registry lists 19 studies whose lead sponsor is Laboratorios Andromaco S.A.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 2, 2022.

Studies

Recruiting first, then most recently updated. Showing 19 of 19. All Grünenthal GmbH studies →

• Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference ProductCompletedNCT05282940Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Eszopiclone 3.0 mg With Regards to Reference ProductCompletedNCT05349396Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference ProductCompletedNCT05332106Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference ProductCompletedNCT05250141Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference ProductCompletedNCT05158192Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference ProductCompletedNCT05083325Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference ProductCompletedNCT04713904Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Fasting ConditionsCompletedNCT04723238Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Feeding ConditionsCompletedNCT04751318Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference ProductCompletedNCT04230070Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference ProductCompletedNCT04194905Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Clotiazepam 5 mg With Regards to Reference ProductCompletedNCT04440423Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference ProductCompletedNCT04422028Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Dienogest 2.0 mg With Regards to Reference ProductCompletedNCT04230083Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference ProductCompletedNCT04193852Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)CompletedNCT03967964Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian ReserveCompletedNCT02268032Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Assessment of a Vaginal Ring With Meloxicam in the Treatment of DysmenorrheaCompletedNCT02255045Phase 2/3

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted after Laboratorios Andromaco S.A. became part of Grünenthal GmbH

• Assessment of a Vaginal Ring With Meloxicam on Ovarian Cycle in Fertile WomenCompletedNCT01839643Phase 1

  Sponsor listed in the registry: Laboratorios Andromaco S.A. · First submitted before Laboratorios Andromaco S.A. became part of Grünenthal GmbH